AI-DBS study: protocol for a longitudinal prospective observational cohort study of patients with Parkinson’s disease for the development of neuronal fingerprints using artificial intelligence
Open Access
Abstract
Introduction Deep brain stimulation (DBS) is a proven effective treatment for Parkinson’s disease (PD). However, titrating DBS stimulation parameters is a labourious process and requires frequent hospital visits. Additionally, its current application uses continuous high-frequency stimulation at a constant intensity, which may reduce efficacy and cause side effects. The objective of the AI-DBS study is to identify patient-specific patterns of neuronal activity that are associated with the severity of motor symptoms of PD. This information is essential for the development of advanced responsive stimulation algorithms, which may improve the efficacy of DBS. Methods and analysis This longitudinal prospective observational cohort study will enrol 100 patients with PD who are bilaterally implanted with a sensing-enabled DBS system (Percept PC, Medtronic) in the subthalamic nucleus as part of standard clinical care. Local neuronal activity, specifically local field potential (LFP) signals, will be recorded during the first 6 months after DBS implantation. Correlations will be tested between spectral features of LFP data and symptom severity, which will be assessed using (1) inertial sensor data from a wearable smartwatch, (2) clinical rating scales and (3) patient diaries and analysed using conventional descriptive statistics and artificial intelligence algorithms. The primary objective is to identify patient-specific profiles of neuronal activity that are associated with the presence and severity of motor symptoms, forming a ‘neuronal fingerprint’. Ethics and dissemination Ethical approval was granted by the local ethics committee of the Amsterdam UMC (registration number 2022.0368). Study findings will be disseminated through scientific journals and presented at national and international conferences.Keywords
Funding Information
- Ministry of Economic Affairs
- Boston Scientific
- Brainlab
- Medtronic
- Stichting ParkinsonFonds
- AMC Foundation
- Amsterdam UMC TKI-PPP (2021, 2023)
- ROMO Foundation
- EU Joint Programme - Neurodegenerative Disease Research (JPND) project (2020)
- ZonMw (04510012210044, 09150162210043)
- Dutch Brain Foundation
- Bial
This publication has 63 references indexed in Scilit:
- Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidityExperimental Neurology, 2009
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing resultsMovement Disorders, 2008
- High-Frequency Stimulation of the Subthalamic Nucleus Suppresses Oscillatory Activity in Patients with Parkinson's Disease in Parallel with Improvement in Motor PerformanceThe Journal of Neuroscience, 2008
- Factors Associated With the Development of Motor Fluctuations and Dyskinesias in Parkinson DiseaseArchives of Neurology, 2006
- Deep brain stimulation of the subthalamic nucleus: A two-edged swordCurrent Biology, 2006
- A Randomized Trial of Deep-Brain Stimulation for Parkinson's DiseaseNew England Journal of Medicine, 2006
- Reduction in subthalamic 8–35 Hz oscillatory activity correlates with clinical improvement in Parkinson's diseaseEuropean Journal of Neuroscience, 2006
- The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index scoreAge and Ageing, 1997
- Reliability, validity, and clinical correlates of apathy in Parkinson's diseaseThe Journal of Neuropsychiatry and Clinical Neurosciences, 1992
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961